TRML TOURMALINE BIO INC

Ownership history in PFIZER INC  ·  4 quarters on record

This page tracks every 13F SEC filing in which PFIZER INC reported a position in TOURMALINE BIO INC (TRML). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
13.91% (2025 Q3)
Avg. % of fund
5.57%
First filed
2024 Q4
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 1,272,214 0% 13.91% $60.8M
2025 Q2 UNCHANGED 1,272,214 0% 3.53% $20.3M
2025 Q1 UNCHANGED 1,272,214 0% 3.86% $19.35B
2024 Q4 INITIATED 1,272,214 1.00% $25.80B
% of Fund (quarterly)
← Back to PFIZER INC Holdings